• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨髓肥大细胞增多症:一项诊断挑战。

Bone Marrow Mastocytosis: A Diagnostic Challenge.

作者信息

Zanotti Roberta, Tanasi Ilaria, Bernardelli Andrea, Orsolini Giovanni, Bonadonna Patrizia

机构信息

Hematology Unit, Department of Medicine, Azienda Ospedaliera Universitaria Integrata di Verona, 37134 Verona, Italy.

Gruppo Interdisciplinare per lo Studio della Mastocitosi (GISM), Azienda Ospedaliera Universitaria Integrata di Verona, 37134 Verona, Italy.

出版信息

J Clin Med. 2021 Apr 1;10(7):1420. doi: 10.3390/jcm10071420.

DOI:10.3390/jcm10071420
PMID:33915965
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8037514/
Abstract

Bone marrow mastocytosis (BMM) represents a provisional, indolent subvariant of systemic mastocytosis (SM). Utilizing WHO criteria, BMM requires bone marrow (BM) involvement and the absence of mastocytosis skin lesions. BMM is characterized by male sex prevalence, a slight increase of serum tryptase levels, low BM mast cells (MC) burden, and an indolent clinical course. BMM shows a strong correlation with severe anaphylaxis, mainly due to an IgE-mediated allergy to bee or wasp venom and, less frequently, to unexplained (idiopathic) anaphylaxis. Furthermore, BMM is often associated with osteoporosis which could be the only presenting symptom of the disease. BMM is an undervalued disease as serum tryptase levels are not routinely measured in the presence of unexplained osteoporosis or anaphylaxis. Moreover, BMM patients are often symptom-free except for severe allergic reactions. These factors, along with typical low BM MCs infiltration, may contribute to physicians overlooking BMM diagnosis, especially in medical centers that lack appropriately sensitive diagnostic techniques. This review highlights the need for a correct diagnostic pathway to diagnose BMM in patients with suspected symptoms but lacking typical skin lesions, even in the case of normal serum tryptase levels. Early diagnosis may prevent potential life-threatening anaphylaxis or severe skeletal complications.

摘要

骨髓肥大细胞增多症(BMM)是系统性肥大细胞增多症(SM)的一种暂时的、惰性的亚型。根据世界卫生组织(WHO)的标准,BMM需要有骨髓(BM)受累且无肥大细胞增多症的皮肤病变。BMM的特点是男性患病率较高、血清类胰蛋白酶水平略有升高、骨髓肥大细胞(MC)负荷较低以及临床病程呈惰性。BMM与严重过敏反应密切相关,主要是由于对蜜蜂或黄蜂毒液的IgE介导的过敏反应,较少见的是原因不明(特发性)的过敏反应。此外,BMM常与骨质疏松症相关,而骨质疏松症可能是该疾病唯一的表现症状。BMM是一种未得到充分重视的疾病,因为在存在原因不明的骨质疏松症或过敏反应时,血清类胰蛋白酶水平通常不进行常规检测。此外,除了严重的过敏反应外,BMM患者通常没有症状。这些因素,再加上典型的低骨髓MC浸润,可能导致医生忽视BMM的诊断,尤其是在缺乏适当敏感诊断技术的医疗中心。这篇综述强调了对于有疑似症状但缺乏典型皮肤病变的患者,即使血清类胰蛋白酶水平正常,也需要一条正确的诊断途径来诊断BMM。早期诊断可能预防潜在的危及生命的过敏反应或严重的骨骼并发症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3565/8037514/e6e156989d50/jcm-10-01420-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3565/8037514/e6e156989d50/jcm-10-01420-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3565/8037514/e6e156989d50/jcm-10-01420-g001.jpg

相似文献

1
Bone Marrow Mastocytosis: A Diagnostic Challenge.骨髓肥大细胞增多症:一项诊断挑战。
J Clin Med. 2021 Apr 1;10(7):1420. doi: 10.3390/jcm10071420.
2
Venom immunotherapy in patients with mastocytosis and hymenoptera venom anaphylaxis.肥大细胞增多症和蜂毒液过敏患者的毒液免疫疗法。
Immunotherapy. 2011 May;3(5):637-51. doi: 10.2217/imt.11.44.
3
Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM.非侵袭性系统性肥大细胞增多症(SM)无皮肤损伤与昆虫诱导的过敏反应有关,与其他惰性 SM 相比具有独特特征。
J Allergy Clin Immunol. 2014 Feb;133(2):520-8. doi: 10.1016/j.jaci.2013.06.020. Epub 2013 Aug 6.
4
Refined diagnostic criteria for bone marrow mastocytosis: a proposal of the European competence network on mastocytosis.骨髓肥大细胞增多症的精细诊断标准:欧洲肥大细胞增多症专业网络的建议。
Leukemia. 2022 Feb;36(2):516-524. doi: 10.1038/s41375-021-01406-y. Epub 2021 Sep 20.
5
Mastocytosis and related entities: a practical roadmap.肥大细胞病及相关疾病:实用路线图。
Acta Clin Belg. 2023 Aug;78(4):325-335. doi: 10.1080/17843286.2022.2137631. Epub 2022 Oct 19.
6
Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levels.伴有严重蜂类毒液过敏和正常血清类胰蛋白酶水平的克隆性肥大细胞疾病。
J Allergy Clin Immunol. 2015 Jul;136(1):135-9. doi: 10.1016/j.jaci.2014.11.035. Epub 2015 Jan 17.
7
Mastocytosis: the puzzling clinical spectrum and challenging diagnostic aspects of an enigmatic disease.肥大细胞增多症:一种神秘疾病的令人费解的临床谱和具有挑战性的诊断方面。
J Intern Med. 2016 Mar;279(3):211-28. doi: 10.1111/joim.12410. Epub 2015 Sep 8.
8
Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of disease.肥大细胞增多症患者的血清类胰蛋白酶水平:与肥大细胞负荷的相关性及对疾病分类定义的意义
Int Arch Allergy Immunol. 2002 Jun;128(2):136-41. doi: 10.1159/000059404.
9
Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels.对膜翅目昆虫叮咬产生全身反应且血清类胰蛋白酶水平升高的患者中的克隆性肥大细胞疾病。
J Allergy Clin Immunol. 2009 Mar;123(3):680-6. doi: 10.1016/j.jaci.2008.11.018. Epub 2009 Jan 9.
10
High prevalence of anaphylaxis in patients with systemic mastocytosis - a single-centre experience.系统性肥大细胞增多症患者中过敏反应的高患病率——单中心经验
Clin Exp Allergy. 2014 Jan;44(1):121-9. doi: 10.1111/cea.12225.

引用本文的文献

1
Systemic Mastocytosis: State of the Art.系统性肥大细胞增生症:最新进展。
Curr Hematol Malig Rep. 2024 Oct;19(5):197-207. doi: 10.1007/s11899-024-00737-8. Epub 2024 Aug 27.
2
Underlying systemic mastocytosis in patients with unexplained osteoporosis: score proposal.不明原因骨质疏松症患者的潜在系统性肥大细胞增多症:评分建议。
Bone. 2024 Sep;186:117141. doi: 10.1016/j.bone.2024.117141. Epub 2024 May 31.
3
Cognitive, neuropsychiatric and neurological alterations in mastocytosis: A systematic review.肥大细胞增多症的认知、神经精神和神经学改变:一项系统综述。

本文引用的文献

1
Systemic mastocytosis revisited with an emphasis on skeletal manifestations.再探系统性肥大细胞增多症,重点关注骨骼表现。
Radiol Med. 2021 Apr;126(4):585-598. doi: 10.1007/s11547-020-01306-8. Epub 2020 Nov 26.
2
Hypertryptasemia and Mast Cell-Related Disorders in Severe Osteoporotic Patients.重度骨质疏松症患者的高色氨酸血症及肥大细胞相关疾病
Mediators Inflamm. 2020 Oct 20;2020:5785378. doi: 10.1155/2020/5785378. eCollection 2020.
3
Hereditary α tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis.
Clin Transl Allergy. 2023 Dec;13(12):e12319. doi: 10.1002/clt2.12319.
4
Review and Updates on Systemic Mastocytosis and Related Entities.系统性肥大细胞增多症及相关疾病的综述与更新
Cancers (Basel). 2023 Nov 28;15(23):5626. doi: 10.3390/cancers15235626.
5
The diagnostic workup for systemic mastocytosis differs from consensus recommendations: Results of a worldwide survey.系统性肥大细胞增多症的诊断检查与共识性建议不同:一项全球调查的结果
World Allergy Organ J. 2023 Nov 8;16(11):100838. doi: 10.1016/j.waojou.2023.100838. eCollection 2023 Nov.
6
Clinical challenge for gastroenterologists-Gastrointestinal manifestations of systemic mastocytosis: A comprehensive review.内科医生面临的临床挑战-全身性肥大细胞增多症的胃肠道表现:全面综述。
World J Gastroenterol. 2022 Aug 7;28(29):3767-3779. doi: 10.3748/wjg.v28.i29.3767.
7
Systemic Mastocytosis and Other Entities Involving Mast Cells: A Practical Review and Update.系统性肥大细胞增多症及其他涉及肥大细胞的疾病:实用综述与更新
Cancers (Basel). 2022 Jul 17;14(14):3474. doi: 10.3390/cancers14143474.
8
Systemic Mastocytosis: Multidisciplinary Approach.系统性肥大细胞增多症:多学科诊疗方法
Mediterr J Hematol Infect Dis. 2021 Nov 1;13(1):e2021068. doi: 10.4084/MJHID.2021.068. eCollection 2021.
9
Mastocytosis and Mast Cell Activation Disorders: Clearing the Air.肥大细胞增多症和肥大细胞激活障碍:澄清问题。
Int J Mol Sci. 2021 Oct 19;22(20):11270. doi: 10.3390/ijms222011270.
遗传性α-胰蛋白酶血症是肥大细胞增多症中严重介质相关症状的有效遗传生物标志物。
Blood. 2021 Jan 14;137(2):238-247. doi: 10.1182/blood.2020006157.
4
Heritable risk for severe anaphylaxis associated with increased α-tryptase-encoding germline copy number at TPSAB1.与 TPSAB1 中 α-色氨酸酶编码种系拷贝数增加相关的严重过敏反应的遗传风险。
J Allergy Clin Immunol. 2021 Feb;147(2):622-632. doi: 10.1016/j.jaci.2020.06.035. Epub 2020 Jul 24.
5
An increased bone mineral density is an adverse prognostic factor in patients with systemic mastocytosis.骨密度增加是系统性肥大细胞增多症患者的不良预后因素。
J Cancer Res Clin Oncol. 2020 Apr;146(4):945-951. doi: 10.1007/s00432-019-03119-3. Epub 2020 Jan 24.
6
Impact of somatic and germline mutations on the outcome of systemic mastocytosis.体细胞和种系突变对系统性肥大细胞增多症结局的影响。
Blood Adv. 2018 Nov 13;2(21):2814-2828. doi: 10.1182/bloodadvances.2018020628.
7
Hymenoptera Anaphylaxis as a Clonal Mast Cell Disorder.膜翅目过敏反应作为一种克隆性肥大细胞疾病
Immunol Allergy Clin North Am. 2018 Aug;38(3):455-468. doi: 10.1016/j.iac.2018.04.010. Epub 2018 Jun 9.
8
Bone Disease in Mastocytosis.肥大细胞增多症中的骨病
Immunol Allergy Clin North Am. 2018 Aug;38(3):443-454. doi: 10.1016/j.iac.2018.04.013.
9
Venom immunotherapy in patients with allergic reactions to insect stings.虫咬过敏患者的毒液免疫疗法。
Expert Rev Clin Immunol. 2018 Jan;14(1):53-59. doi: 10.1080/1744666X.2018.1413350. Epub 2017 Dec 8.
10
Prevalence and risk factors for fragility fracture in systemic mastocytosis.系统性肥大细胞增多症患者脆性骨折的患病率和危险因素。
Bone. 2017 Dec;105:219-225. doi: 10.1016/j.bone.2017.09.005. Epub 2017 Sep 14.